AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in AIM ImmunoTech Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q2 2021
- Shares held
- 7.30M
- +94.9K (+1.3%) vs. Q2 2021
- Total value
- $14.7M
- −$746.0K (−4.8%) vs. Q2 2021
- New holders
- 6
- 12 more added
- Sold out
- 7
- 7 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AIM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $325.6K |
| Q1 2026 | 18 | $102.8K |
| Q4 2025 | 13 | $119.8K |
| Q3 2025 | 15 | $293.9K |
| Q2 2025 | 12 | $104.8K |
| Q1 2025 | 34 | $590.0K |
| Q4 2024 | 35 | $919.3K |
| Q3 2024 | 33 | $2.43M |
| Q2 2024 | 36 | $3.15M |
| Q1 2024 | 33 | $1.93M |
| Q4 2023 | 38 | $1.83M |
| Q3 2023 | 38 | $1.97M |
| Q2 2023 | 34 | $3.01M |
| Q1 2023 | 36 | $2.05M |
| Q4 2022 | 39 | $1.67M |
| Q3 2022 | 38 | $3.36M |
| Q2 2022 | 40 | $4.68M |
| Q1 2022 | 38 | $7.12M |
| Q4 2021 | 43 | $6.86M |
| Q3 2021 | 38 | $14.7M |
| Q2 2021 | 39 | $15.5M |
| Q1 2021 | 38 | $16.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding AIM ImmunoTech Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 57 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10 | $0 | 0.00% | −7−41.2% | Reduced |
| Jacobi Capital Management LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 228 | $461 | 0.00% | 00.0% | Unchanged |
| Proequities, Inc. | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,455 | $3.00K | 0.00% | +600+70.2% | Added |
| Howe & Rusling Inc | 1,500 | $3.00K | 0.00% | +1,500 | New |
| JPMorgan Chase & Co | 2,598 | $5.00K | 0.00% | +199+8.3% | Added |
| SNS Financial Group, LLC | 10,000 | $20.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 10,793 | $22.0K | 0.00% | −16−0.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 11,200 | $23.0K | 0.00% | −11,900−51.5% | Reduced |
| Traynor Capital Management, Inc. | 11,777 | $23.0K | 0.00% | 00.0% | Unchanged |
| Community Bank, N.A. | 13,226 | $27.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 15,706 | $31.0K | 0.00% | +683+4.5% | Added |
| Qube Research & Technologies Ltd | 15,826 | $32.0K | 0.00% | +15,826 | New |
| LPL Financial LLC | 16,482 | $33.0K | 0.00% | −543−3.2% | Reduced |
| Alpine Global Management, LLC | 18,774 | $38.0K | 0.01% | +18,774 | New |
| Captrust Financial Advisors | 20,000 | $40.0K | 0.00% | 00.0% | Unchanged |
| Arkadios Wealth Advisors | 21,597 | $43.0K | 0.01% | +21,597 | New |
| Bank of New York Mellon Corp | 27,565 | $56.0K | 0.00% | +2,297+9.1% | Added |
| Susquehanna International Group, LLP | 36,149 | $73.0K | 0.00% | +36,149 | New |
| Rockefeller Capital Management L.P. | 40,000 | $80.0K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 41,095 | $82.0K | 0.00% | −26,076−38.8% | Reduced |
| SeaCrest Wealth Management, LLC | 43,563 | $88.0K | 0.01% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 46,679 | $94.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 48,450 | $98.0K | 0.00% | +500+1.0% | Added |
| Millennium Management LLC | 54,376 | $110.0K | 0.00% | +54,376 | New |
| Winton Group Ltd | 82,564 | $167.0K | 0.01% | +27,670+50.4% | Added |
| Northern Trust Corp | 88,416 | $179.0K | 0.00% | +1,190+1.4% | Added |
| Price T Rowe Associates Inc | 116,800 | $236.0K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 148,479 | $300.0K | 0.00% | +40,479+37.5% | Added |
| State Street Corp | 160,413 | $324.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 236,000 | $477.0K | 0.01% | −10,000−4.1% | Reduced |
| Dimensional Fund Advisors LP | 370,643 | $749.0K | 0.00% | +231,483+166.3% | Added |
| Geode Capital Management, LLC | 372,953 | $753.0K | 0.00% | +21,203+6.0% | Added |
| BlackRock Inc. | 828,158 | $1.67M | 0.00% | +5,468+0.7% | Added |
| Vanguard Group Inc | 2,002,856 | $4.05M | 0.00% | +9,700+0.5% | Added |
| Morgan Stanley | 2,384,379 | $4.82M | 0.00% | −123,011−4.9% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −152,848−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −29,269−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −20,316−100.0% | Sold out |
| Lehman & Derafelo Financial Resources LLC | 0 | $0 | 0.00% | −11,100−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9,733−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −14−100.0% | Sold out |